Cargando…

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform

PURPOSE: The methods (IHC/FISH) typically used to assess ER, PR, HER2, and Ki67 in FFPE specimens from breast cancer patients are difficult to set up, perform, and standardize for use in low and middle-income countries. Use of an automated diagnostic platform (GeneXpert®) and assay (Xpert® Breast Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Natalie C., Wong, Wendy, Ho, Kenneth E., Chu, Victor C., Rizo, Annaliza, Davenport, Simon, Kelly, Devon, Makar, Rosemary, Jassem, Jacek, Duchnowska, Renata, Biernat, Wojciech, Radecka, Barbara, Fujita, Tomoyuki, Klein, Jonathan L., Stonecypher, Mark, Ohta, Shoichiro, Juhl, Hartmut, Weidler, Jodi M., Bates, Michael, Press, Michael F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208911/
https://www.ncbi.nlm.nih.gov/pubmed/30120700
http://dx.doi.org/10.1007/s10549-018-4889-5
_version_ 1783366806270902272
author Wu, Natalie C.
Wong, Wendy
Ho, Kenneth E.
Chu, Victor C.
Rizo, Annaliza
Davenport, Simon
Kelly, Devon
Makar, Rosemary
Jassem, Jacek
Duchnowska, Renata
Biernat, Wojciech
Radecka, Barbara
Fujita, Tomoyuki
Klein, Jonathan L.
Stonecypher, Mark
Ohta, Shoichiro
Juhl, Hartmut
Weidler, Jodi M.
Bates, Michael
Press, Michael F.
author_facet Wu, Natalie C.
Wong, Wendy
Ho, Kenneth E.
Chu, Victor C.
Rizo, Annaliza
Davenport, Simon
Kelly, Devon
Makar, Rosemary
Jassem, Jacek
Duchnowska, Renata
Biernat, Wojciech
Radecka, Barbara
Fujita, Tomoyuki
Klein, Jonathan L.
Stonecypher, Mark
Ohta, Shoichiro
Juhl, Hartmut
Weidler, Jodi M.
Bates, Michael
Press, Michael F.
author_sort Wu, Natalie C.
collection PubMed
description PURPOSE: The methods (IHC/FISH) typically used to assess ER, PR, HER2, and Ki67 in FFPE specimens from breast cancer patients are difficult to set up, perform, and standardize for use in low and middle-income countries. Use of an automated diagnostic platform (GeneXpert®) and assay (Xpert® Breast Cancer STRAT4) that employs RT-qPCR to quantitate ESR1, PGR, ERBB2, and MKi67 mRNAs from formalin-fixed, paraffin-embedded (FFPE) tissues facilitates analyses in less than 3 h. This study compares breast cancer biomarker analyses using an RT-qPCR-based platform with analyses using standard IHC and FISH for assessment of the same biomarkers. METHODS: FFPE tissue sections from 523 patients were sent to a College of American Pathologists-certified central reference laboratory to evaluate concordance between IHC/FISH and STRAT4 using the laboratory’s standard of care methods. A subset of 155 FFPE specimens was tested for concordance with STRAT4 using different IHC antibodies and scoring methods. RESULTS: Concordance between STRAT4 and IHC was 97.8% for ESR1, 90.4% for PGR, 93.3% for ERBB2 (IHC/FISH for HER2), and 78.6% for MKi67. Receiver operating characteristic curve (ROC) area under the curve (AUC) values of 0.99, 0.95, 0.99, and 0.85 were generated for ESR1, PGR, ERBB2, and MKi67, respectively. Minor variabilities were observed depending on the IHC antibody comparator used. CONCLUSION: Evaluation of breast cancer biomarker status by STRAT4 was highly concordant with central IHC/FISH in this blinded, retrospectively analyzed collection of samples. STRAT4 may provide a means to cost-effectively generate standardized diagnostic results for breast cancer patients in low- and middle-income countries. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-018-4889-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6208911
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-62089112018-11-09 Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform Wu, Natalie C. Wong, Wendy Ho, Kenneth E. Chu, Victor C. Rizo, Annaliza Davenport, Simon Kelly, Devon Makar, Rosemary Jassem, Jacek Duchnowska, Renata Biernat, Wojciech Radecka, Barbara Fujita, Tomoyuki Klein, Jonathan L. Stonecypher, Mark Ohta, Shoichiro Juhl, Hartmut Weidler, Jodi M. Bates, Michael Press, Michael F. Breast Cancer Res Treat Preclinical Study PURPOSE: The methods (IHC/FISH) typically used to assess ER, PR, HER2, and Ki67 in FFPE specimens from breast cancer patients are difficult to set up, perform, and standardize for use in low and middle-income countries. Use of an automated diagnostic platform (GeneXpert®) and assay (Xpert® Breast Cancer STRAT4) that employs RT-qPCR to quantitate ESR1, PGR, ERBB2, and MKi67 mRNAs from formalin-fixed, paraffin-embedded (FFPE) tissues facilitates analyses in less than 3 h. This study compares breast cancer biomarker analyses using an RT-qPCR-based platform with analyses using standard IHC and FISH for assessment of the same biomarkers. METHODS: FFPE tissue sections from 523 patients were sent to a College of American Pathologists-certified central reference laboratory to evaluate concordance between IHC/FISH and STRAT4 using the laboratory’s standard of care methods. A subset of 155 FFPE specimens was tested for concordance with STRAT4 using different IHC antibodies and scoring methods. RESULTS: Concordance between STRAT4 and IHC was 97.8% for ESR1, 90.4% for PGR, 93.3% for ERBB2 (IHC/FISH for HER2), and 78.6% for MKi67. Receiver operating characteristic curve (ROC) area under the curve (AUC) values of 0.99, 0.95, 0.99, and 0.85 were generated for ESR1, PGR, ERBB2, and MKi67, respectively. Minor variabilities were observed depending on the IHC antibody comparator used. CONCLUSION: Evaluation of breast cancer biomarker status by STRAT4 was highly concordant with central IHC/FISH in this blinded, retrospectively analyzed collection of samples. STRAT4 may provide a means to cost-effectively generate standardized diagnostic results for breast cancer patients in low- and middle-income countries. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-018-4889-5) contains supplementary material, which is available to authorized users. Springer US 2018-08-17 2018 /pmc/articles/PMC6208911/ /pubmed/30120700 http://dx.doi.org/10.1007/s10549-018-4889-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Preclinical Study
Wu, Natalie C.
Wong, Wendy
Ho, Kenneth E.
Chu, Victor C.
Rizo, Annaliza
Davenport, Simon
Kelly, Devon
Makar, Rosemary
Jassem, Jacek
Duchnowska, Renata
Biernat, Wojciech
Radecka, Barbara
Fujita, Tomoyuki
Klein, Jonathan L.
Stonecypher, Mark
Ohta, Shoichiro
Juhl, Hartmut
Weidler, Jodi M.
Bates, Michael
Press, Michael F.
Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
title Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
title_full Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
title_fullStr Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
title_full_unstemmed Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
title_short Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
title_sort comparison of central laboratory assessments of er, pr, her2, and ki67 by ihc/fish and the corresponding mrnas (esr1, pgr, erbb2, and mki67) by rt-qpcr on an automated, broadly deployed diagnostic platform
topic Preclinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208911/
https://www.ncbi.nlm.nih.gov/pubmed/30120700
http://dx.doi.org/10.1007/s10549-018-4889-5
work_keys_str_mv AT wunataliec comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT wongwendy comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT hokennethe comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT chuvictorc comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT rizoannaliza comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT davenportsimon comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT kellydevon comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT makarrosemary comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT jassemjacek comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT duchnowskarenata comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT biernatwojciech comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT radeckabarbara comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT fujitatomoyuki comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT kleinjonathanl comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT stonecyphermark comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT ohtashoichiro comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT juhlhartmut comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT weidlerjodim comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT batesmichael comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform
AT pressmichaelf comparisonofcentrallaboratoryassessmentsoferprher2andki67byihcfishandthecorrespondingmrnasesr1pgrerbb2andmki67byrtqpcronanautomatedbroadlydeployeddiagnosticplatform